4//SEC Filing
Lucas Svetlana 4
Accession 0001209191-23-026065
CIK 0001339970other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 4:53 PM ET
Size
7.1 KB
Accession
0001209191-23-026065
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Lucas Svetlana
Director
Transactions
- Exercise/Conversion
Common stock
2023-04-26+6,000→ 6,000 total - Exercise/Conversion
Restricted Stock Unit
2023-04-26−6,000→ 0 total→ Common Stock (6,000 underlying)
Footnotes (3)
- [F1]Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022.
- [F2]RSUs convert into common stock on a one-for-one basis.
- [F3]The RSUs fully vested one year from the grant date which was April 26, 2022.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001781292
Filing Metadata
- Form type
- 4
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 4:53 PM ET
- Size
- 7.1 KB